Doxcercalciferol | USP | Pharmacopoeia | Reference Standards | PharmaCompass.com

Please Wait

Applying Filters...

Doxcercalciferol

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

15 API Suppliers, 10 USDMF, 2 EU WC, 4 NDC API, 8 Listed Suppliers

FINISHED DOSAGE FORMULATIONS

35 FDF Dossiers, 33 FDA Orange Book, 2 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 10MCG/5ML (2MCG/ML), INJECTABLE;INJECTION - 4MCG/2ML (2MCG/ML), CAPSULE;ORAL - 0.5MCG, CAPSULE;ORAL - 1MCG, CAPSULE;ORAL - 2.5MCG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 7 DKSH, 2 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 4 Actylis, 3 BASF, 1 Finar, 1 Gangwal Chemicals, 1 Kerry, 3 Lonza Capsugel, 1 Pluviaendo, 1 Qualicaps, 2 Roquette, 3 Seppic, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

9 Parenteral, 8 Topical, 8 Empty Capsules, 7 Coating Systems & Additives, 7 Solubilizers, 6 Thickeners and Stabilizers, 5 Fillers, Diluents & Binders, 5 Film Formers & Plasticizers, 3 Coloring Agents, 2 Surfactant & Foaming Agents, 2 Emulsifying Agents, 1 Controlled & Modified Release, 1 Taste Masking

DIGITAL CONTENT

9 News #PharmaBuzz

9 News #PharmaBuzz

MARKET PLACE

6 APIs

6 APIs

REF. STANDARDS & IMPURITIES

1 USP, 1 Others

Xls

Filters

Filters

FILTER :

filter Catalog Number Reset all filters

1 All

01 11225601

filter Description Reset all filters

filter CAS Number Reset all filters

Product Main Page

01

USP

Immuno-Oncology 360

Not Confirmed

Contact us
to update this info